Immune responses in the immunocompromised host
Posted by
filipe@mlcom.fr
on 10 June 2023
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses.
Vallet N, Salmona M, Malet-Villemagne J, Bredel M, Bondeelle L, Tournier S, Mercier-Delarue S, Cassonnet S, [...]
Read morePosted by
filipe@mlcom.fr
on 2 June 2023
System level immune monitoring reveals new pathophysiological features in hepatitis-associated aplastic anemia.
Braudeau C, Delbos L, Couec ML, Danic G, Chevreuil J, Lecuroux C, Grain A, Eveillard M, Rialland-Battisti [...]
Read morePosted by
aline
on 15 December 2022
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse.
Gournay V, Vallet N, Peux V, Vera K, Bordenave J, Lambert M, Corneau A, Michonneau D, Peffault de Latour R, [...]
Read morePosted by
filipe@mlcom.fr
on 8 December 2022
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
Vallet N, Le Grand S, Bondeelle L, Hoareau B, Corneau A, Bouteiller D, Tournier S, Derivry L, Bohineust A, [...]
Read morePosted by
filipe@mlcom.fr
on 5 December 2022
Milestones in acute GVHD pathophysiology.
Socie G, Michonneau D. Nature : Front Immunol. 2022 Dec 5;13:1079708. Doi : [...]
Read morePosted by
filipe@mlcom.fr
on 4 October 2022
Toward practical transparent verifiable and long-term reproducible research using Guix.
Vallet N, Michonneau D, Tournier S. Nature : Sci Data. 2022 Oct 4;9(1):597. Doi : [...]
Read morePosted by
filipe@mlcom.fr
on 9 August 2022
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma.
Cuffel A, Allain V, Faivre L, Di Blasi R, Morin F, Vercellino L, Chevalier MF, Desnoyer A, de Jorna R, [...]
Read morePosted by
aline
on 11 April 2022
CpG-Activated Regulatory B-Cell Progenitors Alleviate Murine Graft-Versus-Host-Disease
Viviane A. Agbogan1, Pauline Gastineau1, Emmanuel Tejerina1, Saoussen Karray2† and Flora Zavala1 Nature : [...]
Read morePosted by
filipe@mlcom.fr
on 9 October 2021
Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy.
Tourret M, Talvard-Balland N, Lambert M, Ben Youssef G, Chevalier MF, Bohineust A, Yvorra T, Morin F, [...]
Read morePosted by
aline
on 15 June 2021
Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease
Gérard Socié, … , Robert Zeiser, Bruce R. Blazar. Nature : J Clin Invest. 2021;131(12):e149296. Doi : [...]
Read more